{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:12:55Z","timestamp":1793722375818,"version":"4.6.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000883","name":"Brown Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000928","name":"Welch Foundation","doi-asserted-by":"publisher","award":["AX-1788"],"award-info":[{"award-number":["AX-1788"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006772","name":"Max and Minnie Tomerlin Voelcker Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006772","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007061","name":"Secretar\u00eda Nacional de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["NI-03-2017"],"award-info":[{"award-number":["NI-03-2017"]}],"id":[{"id":"10.13039\/501100007061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013395","name":"Sistema Nacional de Investigadores","doi-asserted-by":"publisher","award":["SNI-142-2018"],"award-info":[{"award-number":["SNI-142-2018"]}],"id":[{"id":"10.13039\/501100013395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013395","name":"Sistema Nacional de Investigadores","doi-asserted-by":"publisher","award":["SNI-143-2017"],"award-info":[{"award-number":["SNI-143-2017"]}],"id":[{"id":"10.13039\/501100013395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013395","name":"Sistema Nacional de Investigadores","doi-asserted-by":"publisher","award":["SNI-160-2017"],"award-info":[{"award-number":["SNI-160-2017"]}],"id":[{"id":"10.13039\/501100013395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013395","name":"Sistema Nacional de Investigadores","doi-asserted-by":"publisher","award":["SNI-163-2016"],"award-info":[{"award-number":["SNI-163-2016"]}],"id":[{"id":"10.13039\/501100013395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["SC3GM105579"],"award-info":[{"award-number":["SC3GM105579"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["CHE-1455061"],"award-info":[{"award-number":["CHE-1455061"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["CHE-1625963"],"award-info":[{"award-number":["CHE-1625963"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ijpddr.2020.08.002","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T21:30:51Z","timestamp":1597440651000},"page":"56-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Antileishmanial activity of a new chloroquine analog in an animal model of Leishmania panamensis infection"],"prefix":"10.1016","volume":"14","author":[{"given":"Lizzi","family":"Herrera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6949-2782","authenticated-orcid":false,"given":"Alejandro","family":"Llanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kissy","family":"Degracia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1311-1132","authenticated-orcid":false,"given":"Carlos M.","family":"Restrepo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang T.","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3026-1135","authenticated-orcid":false,"given":"Oleg V.","family":"Larionov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5830-6315","authenticated-orcid":false,"given":"Ricardo","family":"Lleonart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia L.","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2020.08.002_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jdcr.2015.11.018","article-title":"Cutaneous leishmaniasis caused by Leishmania (Viannia) panamensis in 2 travelers","volume":"2","author":"Achtman","year":"2016","journal-title":"JAAD Case Rep."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib2","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1128\/iai.61.7.2952-2959.1993","article-title":"Immune responses associated with susceptibility of C57BL\/10 mice to Leishmania amazonensis","volume":"61","author":"Afonso","year":"1993","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib3","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.4049\/jimmunol.168.8.3992","article-title":"CD8+ T cells are required for primary immunity in C57BL\/6 mice following low-dose, intradermal challenge with Leishmania major","volume":"168","author":"Belkaid","year":"2002","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1365-3083.2000.00724.x","article-title":"Distinct innate and acquired immune responses to Leishmania in putative susceptible and resistant human populations endemically exposed to L. (Viannia) panamensis infection","volume":"51","author":"Bosque","year":"2000","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib5","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1086\/324665","article-title":"High intralesional interleukin-10 messenger RNA expression in localized cutaneous leishmaniasis is associated with unresponsiveness to treatment","volume":"184","author":"Bourreau","year":"2001","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib6","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1086\/596508","article-title":"In leishmaniasis due to Leishmania guyanensis infection, distinct intralesional interleukin-10 and Foxp3 mRNA expression are associated with unresponsiveness to treatment","volume":"199","author":"Bourreau","year":"2009","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib7","first-page":"152741","article-title":"Potential use of interleukin-10 blockade as a therapeutic strategy in human cutaneous leishmaniasis","volume":"2015","author":"Castellano","year":"2015","journal-title":"J.\u00a0Immunol. Res."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib8","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1002\/eji.201040384","article-title":"Murine model of chronic L. (Viannia) panamensis infection: role of IL-13 in disease","volume":"40","author":"Castilho","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib9","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1086\/653829","article-title":"T-bet, GATA-3, and Foxp3 expression and Th1\/Th2 cytokine production in the clinical outcome of human infection with Leishmania (Viannia) species","volume":"202","author":"D\u00edaz","year":"2010","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib10","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.4049\/jimmunol.1400728","article-title":"The immunotherapeutic role of regulatory T cells in Leishmania (Viannia) panamensis infection","volume":"193","author":"Ehrlich","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib11","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3389\/fimmu.2016.00212","article-title":"Escaping deleterious immune response in their hosts: lessons from trypanosomatids","volume":"7","author":"Geiger","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1365-3083.1997.d01-96.x","article-title":"Experimental infection of balb\/c mice with Leishmania panamensis and Leishmania mexicana\u202f: induction of early IFN-\u03b3 but not IL-4 is associated with the development of cutaneous lesions","volume":"46","author":"Guevara-Mendoza","year":"1997","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib13","first-page":"260","article-title":"Intralesional versus oral chloroquine in cutaneous leishmaniasis: comparison of outcome, duration of treatment and total dose of drug","volume":"26","author":"Hanif","year":"2016","journal-title":"J.\u00a0Coll. Phys. Surg. Pakistan"},{"key":"10.1016\/j.ijpddr.2020.08.002_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41182-016-0002-0","article-title":"Diffuse and disseminated cutaneous leishmaniasis: clinical cases experienced in Ecuador and a brief review","volume":"44","author":"Hashiguchi","year":"2016","journal-title":"Trop. Med. Health"},{"key":"10.1016\/j.ijpddr.2020.08.002_bib15","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.1039\/C6OB01149G","article-title":"Insights into the structural patterns of the antileishmanial activity of bi- and tricyclic N-heterocycles","volume":"14","author":"Herrera","year":"2016","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib16","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.4049\/jimmunol.164.9.4819","article-title":"In BALB\/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease","volume":"164","author":"Himmelrich","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib17","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.3389\/fimmu.2017.01354","article-title":"Interleukin-4 receptor alpha: from innate to adaptive immunity in murine models of cutaneous leishmaniasis","volume":"8","author":"Hurdayal","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.imlet.2013.12.022","article-title":"The role of IL-4 and IL-13 in cutaneous leishmaniasis","volume":"161","author":"Hurdayal","year":"2014","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib19","article-title":"A\u00a0parasite rescue and transformation assay for antileishmanial screening against intracellular Leishmania donovani amastigotes in THP1 human acute monocytic leukemia cell line","volume":"1\u201314","author":"Jain","year":"2012","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib20","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.165.1.364","article-title":"IL-4-Independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection","author":"Jones","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib21","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4049\/jimmunol.166.2.1141","article-title":"The role of IL-10 in promoting disease progression in leishmaniasis","volume":"166","author":"Kane","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib22","doi-asserted-by":"crossref","DOI":"10.2174\/1385272053369196","article-title":"Recent progress in the synthesis of quinolines","author":"Kouznetsov","year":"2005","journal-title":"Curr. Org. Chem."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib23","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1021\/ol403631k","article-title":"Direct, catalytic, and regioselective synthesis of 2-alkyl-, aryl-, and alkenyl-substituted N -heterocycles from N -oxides","volume":"16","author":"Larionov","year":"2014","journal-title":"Org. Lett."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib24","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1074-7613(00)80342-8","article-title":"IL-4 rapidly produced by V beta 4 V alpha 8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB\/c mice","volume":"6","author":"Launois","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.ijpddr.2020.08.002_bib25","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/nrg1832","article-title":"Genetic susceptibility to infectious disease: lessons from mouse models of leishmaniasis","volume":"7","author":"Lipoldov\u00e1","year":"2006","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib26","doi-asserted-by":"crossref","first-page":"8550","DOI":"10.1038\/srep08550","article-title":"The genome of Leishmania panamensis: insights into genomics of the L. (Viannia) subgenus","volume":"5","author":"Llanes","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib27","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.0105-2896.2004.00190.x","article-title":"Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?","volume":"201","author":"McMahon-Pratt","year":"2004","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib28","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.biopha.2018.10.143","article-title":"In\u00a0vivo antileishmanial efficacy of a naphthoquinone derivate incorporated into a Pluronic\u00ae F127-based polymeric micelle system against Leishmania amazonensis infection","volume":"109","author":"Mendon\u00e7a","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib29","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jaad.2009.06.088","article-title":"New World cutaneous leishmaniasis: updated review of current and future diagnosis and treatment","volume":"63","author":"Mitropoulos","year":"2010","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib30","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.4049\/jimmunol.149.8.2715","article-title":"Changes in the precursor frequencies of IL-4 and IFN-gamma secreting CD4+ cells correlate with resolution of lesions in murine cutaneous leishmaniasis","volume":"149","author":"Morris","year":"1992","journal-title":"J.\u00a0Immunol."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.ijpddr.2020.08.002_bib31","first-page":"131","article-title":"Leishmania panamensis transmission in the domestic environment: the results of a prospective epidemiological survey in Santander, Colombia","volume":"26","author":"Mu\u00f1oz","year":"2006","journal-title":"Biomedica"},{"key":"10.1016\/j.ijpddr.2020.08.002_bib32","first-page":"214","article-title":"In\u00a0vitro activity and in\u00a0vivo efficacy of a combination therapy of diminazene and chloroquine against murine visceral leishmaniasis","volume":"29","author":"Mwololo","year":"2015","journal-title":"J.\u00a0Biomed. Res."},{"issue":"Pt 1","key":"10.1016\/j.ijpddr.2020.08.002_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1017\/S0031182000052379","article-title":"A\u00a0comparative study of susceptibility of inbred and outbred mouse strains compared with hamsters to infection with New World cutaneous leishmaniases","volume":"87","author":"Neal","year":"1983","journal-title":"Parasitology"},{"key":"10.1016\/j.ijpddr.2020.08.002_bib34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1365-3024.2003.00615.x","article-title":"The site of cutaneous infection influences the immunological response and clinical outcome of hamsters infected with Leishmania panamensis","volume":"25","author":"Osorio","year":"2003","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib35","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd1824","article-title":"Opportunities and challenges in antiparasitic drug discovery","volume":"4","author":"Pink","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073177","article-title":"AFLP polymorphisms allow high resolution genetic analysis of American tegumentary leishmaniasis agents circulating in Panama and other members of the Leishmania genus","volume":"8","author":"Restrepo","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.ijpddr.2020.08.002_bib37","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1099\/jmm.0.058115-0","article-title":"Activity of antimalarial drugs in\u00a0vitro and in a murine model of cutaneous leishmaniasis","volume":"62","author":"Rocha","year":"2013","journal-title":"J.\u00a0Med. Microbiol."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib38","first-page":"481","article-title":"Leishmania (Viannia) panamensis-induced cutaneous leishmaniasis in Balb\/c mice: pathology","volume":"74","author":"Rojas","year":"1993","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib39","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/intimm\/dxh313","article-title":"Genetic background influences immune responses and disease outcome of cutaneous L.\u00a0mexicana infection in mice","volume":"17","author":"Rosas","year":"2005","journal-title":"Int. Immunol."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib40","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.4049\/jimmunol.180.9.6139","article-title":"Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions in humans infected with Leishmania braziliensis","volume":"180","author":"Salhi","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1084\/jem.173.1.49","article-title":"A\u00a0mouse model of Leishmania braziliensis braziliensis infection produced by coinjection with sand fly saliva","volume":"173","author":"Samuelson","year":"1991","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib42","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nri2711","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003476","article-title":"T\u00a0cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine","volume":"9","author":"Schwarz","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib44","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0167-5699(91)90063-Y","article-title":"The role of T-cell subsets and cytokines in the regulation of infection","volume":"12","author":"Scott","year":"1991","journal-title":"Immunol. Today"},{"key":"10.1016\/j.ijpddr.2020.08.002_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1570180813666160927113743","article-title":"In\u00a0vivo antimalarial and in\u00a0vitro antileishmanial activity of 4- aminoquinoline derivatives hybridized to isoniazid or sulfa or hydrazine groups","volume":"14","author":"Soares","year":"2017","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib46","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-3024.1985.tb00098.x","article-title":"A\u00a0limiting dilution assay for quantifying Leishmania major in tissues of infected mice","volume":"7","author":"Titus","year":"1985","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib47","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ijid.2011.03.021","article-title":"Recent advances in leishmaniasis treatment","volume":"15","author":"Tiuman","year":"2011","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib48","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.exppara.2009.02.012","article-title":"Leishmania (Viannia) panamensis: an in\u00a0vitro assay using the expression of GFP for screening of antileishmanial drug","volume":"122","author":"Varela-M","year":"2009","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001612","article-title":"In\u00a0vitro and in\u00a0vivo efficacy of ether lipid edelfosine against Leishmania spp. and SbV-resistant parasites","volume":"6","author":"Varela-M","year":"2012","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib50","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12079-015-0302-x","article-title":"A\u00a0network map of Interleukin-10 signaling pathway","volume":"10","author":"Verma","year":"2016","journal-title":"J.\u00a0Cell Commun. Signal."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib51","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00358-17","article-title":"Efficacy of paromomycin-chloroquine combination therapy in experimental cutaneous leishmaniasis","volume":"61","author":"Wijnant","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.08.002_bib52","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.immunol.21.120601.141142","article-title":"IL-13 effector functions","volume":"21","author":"Wynn","year":"2003","journal-title":"Annu. Rev. Immunol."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320720300221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320720300221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:51:16Z","timestamp":1761922276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320720300221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":52,"alternative-id":["S2211320720300221"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2020.08.002","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antileishmanial activity of a new chloroquine analog in an animal model of Leishmania panamensis infection","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2020.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}